Business Description
This fund puts the vast majority of its money into companies that work in genomics and biotechnology, following a specific market index created by Solactive AG. These businesses are chosen because they stand to gain from ongoing breakthroughs in genetic science and related technologies. The fund concentrates its holdings rather than spreading investments broadly across many different sectors.
